Literature DB >> 33152465

The role of public health versus invasive coronary interventions in the decline of coronary heart disease mortality.

Ehab E Tuppo1, Mihir P Trivedi2, John B Kostis3, Julian Daevmer2, Javier Cabrera3, William J Kostis3.   

Abstract

PURPOSE: There has been considerable debate on the extent to which the decline in coronary heart disease (CHD) mortality has been caused by better control of coronary risk factors in the general population or is the result of invasive coronary interventions in symptomatic individuals.
METHODS: Using the Myocardial Infarction Data Acquisition System, a statewide database of all cardiovascular hospital admissions in New Jersey, we examined time trends in incidence of death from CHD in the Years 2000-2014 in persons with a history of hospitalization for CHD in the previous 10 years and those without such a history.
RESULTS: Over the 10-year study period, there was a marked decline in CHD-related mortality in both persons with a history of CHD and persons without a history of CHD. The decline occurred across all gender, racial, and age groups and was higher in those without a prior history of CHD.
CONCLUSIONS: This adds more evidence that the decline in CHD was not only because of advanced invasive medical and surgical treatments but also equally because of improved lifestyle, pharmacologic treatment of risk factors for CHD, and public health interventions.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Epidemiology; Mortality; Public health

Mesh:

Year:  2020        PMID: 33152465     DOI: 10.1016/j.annepidem.2020.10.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  1 in total

1.  Proprotein convertase subtilisin/kexin type 9 inhibitor non responses in an adult with a history of coronary revascularization: A case report.

Authors:  Liu Yang; Yan-Yan Xiao; Liang Shao; Chang-Sheng Ouyang; Yao Hu; Bin Li; Li-Feng Lei; Hong Wang
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.